1. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011; 7(1): 31.

2. Bell GS, Sander JW. The epidemiology of epilepsy: The size of the problem. Seizure 2001; 10(4): 306-16.

3. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: excitability and inflammation. Trends Neurosci 2013; 36(3): 174-84.

4. Daley JT, DeWolfe JL. Sleep, circadian rhythms, and epilepsy. Curr Treat Options Neurol 2018; 20(11): 47.

5. Huwait EA, Al-Ghamdi MA. Protective role of carnitine synergized with vitamin E against isoproterenol induced cardiac infarction in rats. Afr J Tradit Complement Altern Med 2017; 14(2): 25-32.

6. Florentin M, Elisaf M, Rizos C, Nikolaou V, Bilianou E, Pitsavos C, et al. L-carnitine/Simvastatin reduces lipoprotein (a) levels compared with simvastatin monotherapy: a randomized double-blind placebo-controlled study. Lipids 2017; 52(1): 1-9.

7. Rasmussen J, Nielsen OW, Janzen N, Duno M, Køber L, Steuerwald U, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis 2014; 37(2): 215-22.

8. Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab 2010; 7(1): 30.

9. El-Hattab A.W. Scaglia F. Disorders of carnitine biosynthesis and transport. Mol Gent Metab 2015. 116(3): 107-12.

10. Karlic H, Lohninger A. Supplementation of L-carnitine in athletes: does it make sense? Nutrition 2004; 20(7-8): 709-15.

11. Stephens FB, Constantin‐Teodosiu D, Greenhaff PL. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol 2007; 581(2): 431-44.

12. Tarantini G, Scrutinio D, Bruzzi P, Boni L, Rizzon P, Iliceto S. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. Cardiology 2006; 106(4): 215-23.

13. Fielding R, Riede L, Lugo JP, Bellamine A. L-carnitine supplementation in recovery after exercise. Nutrients 2018; 10(3): 349.

14. Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 2015; 163(7): 1585-95.

15. Ricardo A, Cruciani, Manuel Revuelta, Ella Dvorkin, Peter Homel, Pauline Lesage, Nora Esteban-Cruciani. L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study. HIV AIDS (Auckl) 2015; 7: 65-73.

16. Gröber U, Holzhauer P, Kisters K, Holick MF, Adamietz IA. Micronutrients in oncological intervention. Nutrients, 2016; 8(3): 163.

17. Bene J, Hadzsiev K, Melegh B. Role of carnitine and its derivatives mn the development and management of type 2 diabetes. Nutr Diabetes 2018; 8(1): 1-10.

18. Kobayashi S, Iwamoto M, Kon K, Waki H, Ando S, Tanaka Y. Acetyl‐l‐carnitine improves aged brain function. Geriatr Gerontol Int 2010; 10: S99-S106.

19. Rubio-Gozalbo ME, Bakker JA, Waterham HR, Wanders RJA. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med 2004; 25(5-6): 521-32.

20. Gholipur-Shahraki T, Feizi A, Mortazavi M, Badri S. Effects of carnitine on nutritional parameters in patients with chronic kidney disease: an updated systematic review and meta-analysis. J Res Pharm Pract 2018; 7(2): 57.

21. Hitiris N, Brodie MJ. Modern antiepileptic drugs: guidelines and beyond. Curr Opin Neurol 2006; 19(2): 175-80.

22. Brodie MJ, Antiepileptic drug therapy the story so far. Seizure 2010; 19(10): 650-5.

23. Łukawski K, Gryta P, Łuszczki J, Czuczwar SJ. Exploring the latest avenues for antiepileptic drug discovery and development. Expert Opin Drug Discov 2016; 11(4): 369-82.

24. Ayala-Guerrero F, Reyes A, Mexicano G. Effect of Epilepsy and Antiepileptic Treatment on Reference and Working Memory. J Neurol Disord Stroke 2014; 2(3): 1065.

25. Witt JA, Helmstaedter C, Monitoring the cognitive effects of antiepileptic pharmacotherapy- approaching the individual patient. Epilepsy & Behav 2013; 26(3): 450-6.

26. Beuchat I, Novy J, Rossetti AO. Newer Antiepileptic Drugs for Status Epilepticus in Adults: What’s the Evidence? CNS Drugs 2018; 32(3): 259-67.

27. Choo BKM, Kundap UP, Bin Johan Arief MF, Kumari Y, Yap JL, Wong CP, et al. Effect of newer anti-epileptic drugs (AEDs) on the cognitive status in pentylenetetrazol induced seizures in a zebrafish model. Prog Neuropsychopharmacol Biol Psychiatry 2019; 92: 483-93.

28. Arafa HM. Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids. Toxicology 2008; 254(1-2): 51-60.

29. Khakwani A, Gannon D. L-carnitine supplementation as a potential therapy for suspected hyperammonaemic encephalopathy. R Coll Physicians Edinb 2019; 49: 301-3.

30. Maldonado C, Vázquez M, Fagiolino P. Potential therapeutic role of carnitine and acetylcarnitine in neurological disorders. Curr Pharm Des 2020; 26(12): 1277-85.

31. Cao Y, Wang Y, Liu CJ, Wang Lx, Han ZW, Wang CB. Comparison of pharmacokinetics of L-carnitine, Acetyl-L-carnitine and Propionyl-Lcarnitine after single oral administration of L-carnitine in healthy volunteers. Clin Invest Med 2009; 32(1): E13-9.

32. Tolou-Ghamari Z, Palizban AA. Review of sodium valproate clinical and biochemical properties. Zahedan J Res Med Sci 2015; 17(8): e2207. [in Persian]

33. Bagheri S, Heydari A, Alinaghipour A, Salami M. Effect of probiotic supplementation on seizure activity and cognitive performance in PTZ-induced chemical kindling. Epilepsy Behav 2019; 95: 43-50.

34. Jamali H, Heydari A. Effect of dextromethorphan/quinidine on pentylenetetrazole-induced clonic and tonic seizure thresholds in mice. Neuroscience Letters 2020 Apr 20:134988.

35. Esmaili Z, Heydari A. Effect of acute caffeine administration on PTZ-induced seizure threshold in mice: Involvement of adenosine receptors and NO-cGMP signaling pathway. Epilepsy Res 2019; 149: 1-8.

36. Huang RQ, Bell-Horner CL, Dibas MI, Covey DF, Drewe JA, Dillon GH. Pentylenetetrazole-induced inhibition of recombinant γ-aminobutyric acid type A (GABAA) receptors: mechanism and site of action. J Pharmacol Exp Ther 2001; 298(3): 986-95.

37. Cattaneo CI, Ressico F, Valsesia R, D’Innella P, Ballabio M, Fornaro M. Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report. Medicine 2017; 96(39): e8117. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626280/

38. Malaguarnera M, Pistone G, Elvira R, Leotta C, Scarpello L, Liborio R. Effects of L-carnitine in patients with hepatic encephalopathy. World J Gastroenterol 2005; 11:7197–7202.

39. El Mously S, Abdel Ghaffar H, Magdy R, Hamza S, Mansour M. Carnitine deficiency in epileptic children treated with a diversity of anti-epileptic regimens. Egypt J Neurol Psychiatr Neurosurg. 2018; 54(1):37.

40. Trinka E, Höfler J, Zerbs A, Brigo F. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs 2014; 28(7): 623-39.

41. Smeland OB, Meisingset TW, Sonnewald U. Dietary supplementation with acetyl-l-carnitine in seizure treatment of pentylenetetrazole kindled mice. Neurochem Int 2012; 61(4): 444-54.

42. Roghani M, Baluchnejadmojarad T, Pooladvand S. The effect of acetyl l carnitine on prevention of hippocampal neurodegeneration and mossy fiber sprouting in an experimental model of temporal lobe epilepsy in rat. Stud Med Sci 2014; 25 (8) :718-726. [in persian]

43. Hussein AM, Adel M, El-Mesery M, Abbas KM, Ali AN, Abulseoud OA. L-carnitine modulates epileptic seizures in pentylenetetrazole-kindled rats via suppression of apoptosis and autophagy and upregulation of hsp70. Brain Sci 2018: 8(3): 45.